Shimamura, A
Studies show this is because oral tablets are absorbed by the digestive system, causing the medication to be distributed slowly throughout the body, reducing its targeting ability and effectiveness
Subsequently, a more efficient product, called Ketionin , containing DL-Met, stabilizers, antioxidants, flavoring agents, CaCO 3 , tristearin, and oleic acid was produced and presented a better intestinal release of Met ( allowed approximately 80% of the Met to escape ruminal degradation, with approximately 19% of the original as-fed product being bioavailable Met (Ordway, 2005)
It is worth noting that one of the recently approved ALS therapies (sodium phenylbutyrate + TUDCA, as mentioned earlier) highlights the intersection of microbiome-related metabolism and neurodegeneration [224]
New data shows it primes immune cells to respond faster to viral and bacterial threats